Retraction IN OUR REPORT "CLAVATA3, A MULTIMERIC ligand for the CLAVATA1 receptorkinase," an analysis of CLV3 function in Arabidopsis, we concluded that CLV3 acted as a ligand for the CLV1 receptorkinase (1). The work was based on the use of polyclonal antibodies to CLV3, and the data presented indicated that the antibodies specifically detected CLV3 from Arabidopsis and cauliflower extracts and CLV3 fusion proteins expressed in Escherichia coli. All experiments involved in the production and use of these antibodies had been conducted by a single lead investigator.
Incorporating Science into Decision-Making ALAN LESHNER'S EDITORIAL "PUBLIC ENGAGEment with science" (14 Feb., p. 977) highlights a conundrum: Why is science often ignored in important societal decisions, even as the call for decisions based on sound science escalates? One reason is that decision-making is often driven by a variety of nonscientific, adversarial, and stakeholder dynamics (1) . Thus, even though science helps inform choices, it is only one of many values and interests considered by each stakeholder. In response to this emerging challenge, scientists at the U.S. Geological Survey (USGS) are exploring the problems of incorporating science into value-laden societal decisions. This research includes designing experiments that will assess the appropriateness of using the new and emerging approach of Joint Fact Finding (2, 3 evolved: hydroxyproline and hydroxylysine. Probably originating from within fungal-like protists (1), this development permitted the subsequent evolution of the structural glycoproteins collagen and extensin. Functional "make-do" substitutes for these proteins using some combination of the 20 "standard" amino acids had not been achieved. Thus, the evolution of these two amino acids and their insertion into fibrous proteins was a major biochemical breakthrough for complex life. It opened the way for the origin, evolution, and diversification of the Metazoa and Metaphyta. These "rare" amino acids require molecular oxygen and oxygenase enzymes for their synthesis. The proteins also use oxygen and oxidases for the intermolecular cross-links that are important for fibril strengthening and chemical resistance. Because of this mandatory, energy-expensive, and metabolically competitive need for molecular oxygen, it is likely that the delayed appearance of complex multicellular life until the latter part of the Precambrian could be due, in part, to the lower amounts of atmospheric free oxygen available earlier on (1-3). Giving Credit to the First Linear Collider THE FIRST OF THE THREE WELL-DONE ARTICLES on the high-energy physics community's effort to realize a world-wide consortium to build the World Linear Collider accelerator project ("Collision course with reality," News Focus, Adrian Cho, 21 Feb., p. 1168) makes one error of fact. It says, "The proposed electron-positron accelerator would be unlike any ever built." This is not so. To start a $5-billion project without having fully tested out the fundamental accelerator physics issues would make us even crazier than the author implies that we are.
KENNETH M. TOWE
The first linear collider (SLC), built at the Stanford Linear Accelerator Center (SLAC), began operation at energies up to 95 GeV in 1987. The critical issue for this new kind of accelerator was the ability to make what were then regarded as impossibly small beams stably collide with each other. It took some time to understand new accelerator physics problems and learn how to operate this machine. Many of the physicists involved in the new design competition discussed in the article took part in that work. The world accelerator physics community accepted the possibility of a very-high-energy collider when the SLC bettered its original beam size design goals, routinely operating for experiments with beams at the collision point of 0.5 by 1.0 µm.
The article by Charles Seife ("Why physicists long for the straight and narrow," News Focus, 21 Feb., p. 1171) asserts that the Large Electron-Positron Collider (LEP) at CERN and the Tevatron at the Fermi National Accelerator Laboratory (FNAL) "filled in the details of the Standard Model." In fact, the SLC delivered beams for the Mark II and SLD detectors. The linear collider makes it relatively straightforward to deliver polarized electron beams, and SLD used polarization asymmetries to make the most precise determination of the weak interaction "Weinberg" angle. The unique operating environment of the SLC permitted micrometer level reconstruction of the tracks of short-lived particles. The polarization and precision vertex reconstruction led to measurements more precise in some cases than comparable results from the combined four LEP detectors with their 30-times-larger sample of Z decays. For, example, the most stringent constraint on the Standard Model Higgs boson mass is due to the SLC/SLD program.
Today's international competition between technologies and for a home site is the natural evolution of what has been an enormously productive international collaboration in the R&D phase of collider design. Since the late 1980s, SLAC, KEK, DESY, and FNAL have cooperated in building and operating facilities to test key concepts of an advanced linear collider. The collaborative R&D ensured that everyone was part of the determination of the feasibility and of setting the parameters of a future facility. It has worked beautifully and has sped up development. The present rivalry is a natural consequence of having to choose a site, and it will turn again to collaboration when a site is chosen. Estimates of such costs are usually provided by the regulated industry itself in the course of fending off further regulation and assume the use of traditional control strategies (such as local exhaust ventilation)-and, as such, tend to be inflated. An important study of the costs of Occupational Safety and Health Administration (OSHA) regulation by the now defunct Office of Technology Assessment found that companies consistently complied with new regulations through innovative changes in production methods and products at less cost than the companies had originally estimated (1) . In many cases, there was no net cost per life saved; both lives and dollars were saved as more efficient equipment and production methods came into use in response to the new demand for safety. We observed this trend in the wake of OSHA's methylene chloride regulation (mentioned in Kaiser's article as costing $12.7 million per life saved). Our survey of companies in Massachusetts found that most of them had changed production methods to eliminate or reduce use of the chemical and that they had found numerous benefits (including saving money) and few problems with their multiple innovations (2). Regulation is not only good for health-it can be good for the U.S. economy.
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